Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Infectious Diseases

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/650543PMID 20102271PMCID PMC2825289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel

  2010cited by this paper
• Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.

  2009influential reference
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.

  2008influential reference
• Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

  2008cited by this paper
• Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy

  2008cited by this paper
• Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society–USA Panel

  2008cited by this paper
• Racial Differences in Virologic Failure Associated With Adherence and Quality of Life on Efavirenz-Containing Regimens for Initial HIV Therapy: Results of ACTG A5095

  2007cited by this paper
• Detection of minor drug-resistant populations by parallel allele-specific sequencing

  2007cited by this paper
• The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies

  2007cited by this paper
• High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998–2004

  2007cited by this paper
• A comparison of three initial antiretroviral AIDS regimens.

  2007influential reference
• Corrigendum: Detection of minor drug-resistant populations by parallel allele-specific sequencing

  2007cited by this paper
• Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations.

  2007cited by this paper
• Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.

  2006cited by this paper
• A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.

  2006cited by this paper
• Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.

  2005cited by this paper
• Detection of minor populations of drug-resistant HIV-1 in acute seroconverters

  2005cited by this paper
• Detection of Minority Populations of HIV-1 Expressing the K103N Resistance Mutation in Patients Failing Nevirapine

  2005cited by this paper
• Genome sequencing in microfabricated high-density picolitre reactors

  2005cited by this paper
• Role of Minority Populations of Human Immunodeficiency Virus Type 1 in the Evolution of Viral Resistance to Protease Inhibitors

  2004cited by this paper
• Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine.

  2004cited by this paper
• Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns

  2004cited by this paper
• Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

  2004influential reference
• Accuracy of the TRUGENE HIV-1 Genotyping Kit

  2003cited by this paper
• Predictors of the Virological Response to a Change in the Antiretroviral Treatment Regimen in HIV-1-Infected Patients Enrolled in a Randomized Trial Comparing Genotyping, Phenotyping and Standard of Care (Narval Trial, Anrs 088)

  2002cited by this paper
• Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

  2002cited by this paper
• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection

  2000cited by this paper
• Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

  2000cited by this paper
• Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments

  2000cited by this paper
• Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

  2000cited by this paper
• A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

  2000cited by this paper
• A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

  2000cited by this paper
• Analysis of case-cohort designs.

  1999cited by this paper
• Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting.

  1999cited by this paper
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

  1998cited by this paper
• Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products

  1997cited by this paper
• Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients

  1996cited by this paper
• A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208.

  1995cited by this paper
• Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

  1994cited by this paper
• Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective.

  1990cited by this paper
• Antiretroviral Drug Resistance Testing in Adult Hiv-1 Infection: 2008 Recommendations of an International Aids Society–usa Panel

  year unknowncited by this paper

• HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018–2024

  2025cites this paper
• Advancements in laboratory diagnostics for HIV/MTB coinfection: Integrating conventional methods with emerging technologies

  2025cites this paper
• Antiretroviral therapy use, self‐reported adherence, and viral suppression among women living with HIV in Canada

  2025cites this paper
• “Outlaw” mutations in quasispecies of SARS-CoV-2 inhibit replication

  2024cites this paper
• Recent advances on the therapeutic potential with Ocimum species against COVID-19: A review

  2024cites this paper
• Beyond surveillance: leveraging the potential of next generation sequencing in clinical virology

  2024cites this paper
• Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation

  2024cites this paper
• Four Decades of HIV: Global Trends, Testing Assays, Treatment, and Challenges

  2024cites this paper
• Resistance‐associated mutations to the anti‐SARS‐CoV‐2 agent nirmatrelvir: Selection not induction

  2024cites this paper
• Patient / Adherence-Related Factors ( see Adherence to the Continuum of Care )

  2023cites this paper
• Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing.

  2023cites this paper
• Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China.

  2023cites this paper
• Virologic status and pattern of drug resistance mutation among ART-experienced HIV-infected patients in Butuo: County, China.

  2023cites this paper
• Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study

  2023cites this paper
• Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.

  2023cites this paper
• From viral democratic genomes to viral wild bunch of quasispecies

  2023cites this paper
• Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance

  2022cites this paper
• Towards Next-Generation Sequencing for HIV-1 Drug Resistance Testing in a Clinical Setting

  2022influential citation
• Low-frequency HIV-1 drug resistance mutations in antiretroviral naïve individuals in Botswana

  2022cites this paper
• Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019

  2022cites this paper
• Drug-Resistance Testing

  2022cites this paper
• Immunocompetent Human 3D Organ-Specific Hormone-Responding Vaginal Mucosa Model of HIV-1 Infection

  2021cites this paper
• Drugs Resistance and Treatment Failure in HIV and/or AIDS

  2021cites this paper
• HIV_A_295512 261..269

  2021cites this paper
• First-Line Antiretroviral Regimen Failure and Determinants in an Urban HIV Clinic at Phramongkutklao Hospital, Bangkok, Thailand: 20 Years Experience

  2021cites this paper
• Near Real-Time Identification of Recent HIV Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by MPID-NGS in North Carolina.

  2020cites this paper
• Long-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice

  2020cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

  2020cites this paper
• Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping

  2020cites this paper
• In vivo drug resistance mutation dynamics from the early to chronic stage of infection in antiretroviral-therapy-naïve HIV-infected men who have sex with men

  2020cites this paper
• Combination therapy against human infections caused by viruses

  2020cites this paper
• High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy

  2020cites this paper
• Factors Influencing Viral Load Non-suppression among People Living with HIV (PLHIV) in Borno State, Nigeria: A Case of Umaru Shehu Ultra-Modern Hospital

  2020cites this paper
• Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa

  2020cites this paper
• A single variant sequencing method for sensitive and quantitative detection of HIV-1 minority variants

  2020cites this paper
• SIRA-HIV: A User-friendly System to Evaluate HIV-1 Drug Resistance from Next-generation Sequencing Data

  2020cites this paper
• Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays

  2020cites this paper
• Pretreatment HIV drug resistance spread within transmission clusters in Mexico City

  2019cites this paper
• Detection of pretreatment minority HIV-1 reverse transcriptase inhibitor-resistant variants by ultra-deep sequencing has a limited impact on virological outcomes

  2019cites this paper
• Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naïve individuals: A systematic review of detection methods, prevalence, and clinical impact.

  2019cites this paper
• Viral evolution in the cell‐associated HIV‐1 DNA during early ART can lead to drug resistance and virological failure in children

  2019cites this paper
• Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru

  2019influential citation
• Increased uptake of early initiation of antiretroviral therapy and baseline drug resistance testing in San Francisco between 2001 and 2015

  2019cites this paper
• Genotypic and Phenotypic Resistance Assays

  2019cites this paper
• A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance

  2019cites this paper
• Factors Influencing Adherence to Antiretroviral Therapy among HIV Positive Adolescents at Adult Infectious Diseases Center in Lusaka, Zambia

  2019cites this paper
• Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia

  2019cites this paper
• Linked dual-class HIV resistance mutations are associated with treatment failure.

  2019cites this paper
• Drug Resistance Evolution in HIV in the Late 1990s: Hard Sweeps, Soft Sweeps, Clonal Interference and the Accumulation of Drug Resistance Mutations

  2019cites this paper
• Molecular evolution of biological sequences

  2018cites this paper
• Impact des inhibiteurs de l'intégrase sur la constitution et la compartimentalisation du réservoir viral

  2018cites this paper
• Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.

  2018cites this paper
• Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay

  2018cites this paper
• Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors

  2018cites this paper
• Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

  2018cites this paper
• Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression

  2018cites this paper
• Within-patient mutation frequencies reveal fitness costs of CpG dinucleotides and drastic amino acid changes in HIV

  2018cites this paper
• Chuma na Uchizi: A Livelihood Intervention to Increase Food Security of People Living with HIV in Rural Zambia

  2018cites this paper
• Investigation of the HIV diversity in the Cape Winelands, Overberg and West Coast districts of the Western Cape Province of South Africa

  2017cites this paper
• The Role of HIV‐1 Drug‐Resistant Minority Variants in Treatment Failure

  2017cites this paper
• Soft sweeps and beyond: Understanding the patterns and probabilities of selection footprints under rapid adaptation

  2017cites this paper
• RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients

  2017cites this paper
• Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy

  2017cites this paper
• Primary HIV-1 Drug Resistant Minority Variants.

  2017cites this paper
• Promises and pitfalls of Illumina sequencing for HIV resistance genotyping.

  2017cites this paper
• Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015

  2017cites this paper
• Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome

  2017cites this paper
• Effect of zinc on immune recovery in HIV patients. Medellín 2013. Randomized controlled trial

  2017cites this paper
• Deep sequencing for HIV-1 clinical management.

  2017cites this paper
• Limited clinical benefit of minority K 103 N and Y 181 C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients

  2017cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV

  2017cites this paper
• No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men

  2017cites this paper
• Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation

  2016cites this paper
• iagnóstico de laboratorio de la infección por el VIH, del tropismo viral y de las esistencias a los antirretrovirales

  2016cites this paper
• HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission

  2016cites this paper
• Next generation sequencing demonstrates minor variant HIV drug resistance mutations

  2016cites this paper
• Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children – a EuroCoord-CHAIN-EPPICC joint project

  2016cites this paper
• Within-patient HIV mutation frequencies reveal fitness costs of CpG dinucleotides, drastic amino acid changes and G→A mutations

  2016cites this paper
• British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015

  2016influential citation
• Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay

  2016cites this paper
• How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact

  2016cites this paper
• Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?

  2016cites this paper
• Next-Generation Virus Genotyping for HIV-1 Surveillance and Clinical Management

  2016cites this paper
• Food security and antiretroviral therapy adherence among people living with HIV in Lundazi District, Zambia: A pilot study

  2016cites this paper
• Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups

  2016cites this paper
• An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies

  2016cites this paper
• Risk factors that may modify the innate and adaptive immune responses in periodontal diseases.

  2016cites this paper
• Deep sequencing analysis of HIV‐1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE

  2016cites this paper
• Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

  2016cites this paper
• Molecular Detection and Characterization of Human Immunodeficiency Virus Type 1

  2016cites this paper
• Clinical impact of HIV-1 resistance against nonnucleoside analogue reverse transcriptase Inhibitors. Impacte clínic de la resistència del VIH-1 als inhibidors de la transcriptassa inversa no anàlegs de nucleòsids

  2015cites this paper
• Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeq

  2015cites this paper
• Assessment of Etravirine Resistance in HIV-1-Infected Paediatric Patients using Population and Deep Sequencing: Final Results of the PIANO Study

  2015cites this paper
• The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogens

  2015influential citation
• This information is current as Immunodeficiency Virus Infection Timing of Immune Escape in Simian Rather than Viral Variability Determine the T Cell Kinetics + Epitope-Specific CD 8

  2015cites this paper
• Ongoing HIV Transmission and the HIV Care Continuum in North Carolina

  2015cites this paper
• Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.

  2015cites this paper
• Tools and applications for DNA sequencing in the clinical management of viral infectious diseases : examples from HIV-1 and HCV

  2015cites this paper
• HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument

  2015cites this paper
• HIV infection

  2015cites this paper